Conclusion: Right after twelve weeks of remedy, ad libitum Electricity consumption was substantially lessen with semaglutide vs placebo with a corresponding lack of overall body pounds noticed with semaglutide.The first endpoint was the intraindividual change in HbA1c from baseline in response to semaglutide or dapagliflozin in participants with S